Delivery Order SPE2DE24D0013-SPE2D625F7SM9
- Not listed
- This delivery order, valued at $6,800, was awarded to Cepheid Inc. on July 28, 2025, for molecular diagnostic solutions related to COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) testing. The contract operates under a firm fixed-price structure with no set-aside designation and is funded by the Defense Department's Medical Supply Chain organization. Performance will take place at Cepheid's headquarters in Sunnyvale, California. This award is likely issued under one of Cepheid's...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $20.4K to Cepheid Inc. on July 25, 2025, for molecular diagnostic solutions. Designated as Contract Number 4568895371 with the identifier XPCOV2/FLU/RSV-10, this firm fixed-price delivery order is set to be completed by August 1, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The contract involves diagnostics testing solutions, specifically targeting...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $2,471.70 by the Defense Department's Medical Supply Chain organization on July 18, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order carries no set-aside designation and represents procurement of diagnostic equipment, reagents, or testing services from Cepheid's core product portfolio, which includes GeneXpert...
- The Defense Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic manufacturer headquartered in Sunnyvale, California, on July 21, 2025, with an ultimate completion date of July 28, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, carries no set-aside designation and pertains to COVID-19, influenza, and respiratory syncytial virus diagnostic solutions. The contract represents work performed under Cepheid's existing indefinite...
- This delivery order, awarded July 28, 2025, represents a $3,400 firm fixed-price contract between the Defense Logistics Agency's Medical Supply Chain division and Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California. The order is designated for respiratory pathogen testing, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection, with performance to be completed by August 4, 2025. No set-aside designation was applied to this procurement....
- Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, received a $6.8K delivery order from the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, for the KIT XPERT XPRESS COVID-19/FLU/RSV + Molecular Biology diagnostic kit. This firm fixed-price delivery order, with performance completion targeted for July 29, 2025, carries no set-aside designation and represents part of Cepheid's ongoing supply of molecular diagnostic testing solutions to...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $13,096.80 to Cepheid Inc. on July 28, 2025, for molecular diagnostic testing solutions. This firm fixed-price delivery order, designated 4568920464 and titled XPCOV2/FLU/RSV-10, carries an ultimate completion date of August 11, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The contract involves diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $3,400 firm fixed-price delivery order on July 28, 2025, for COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) diagnostic testing supplies. The delivery order, contract number 4568910321, is set to be completed by August 4, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract is funded by the Defense Department's Medical Supply Chain entity and utilizes no...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $5,174.64 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPCOV2/FLU/RSV-10, has an ultimate completion date of July 30, 2025, and carries no set-aside designation. The contract references diagnostic testing for COVID-19, influenza, and respiratory syncytial virus (RSV), consistent with...
- Cepheid has been awarded a delivery order valued at $7,276 under contract number 4568920470 for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. This firm fixed-price delivery order, issued by the Medical Supply Chain division of the Department of Defense, will be performed in Sunnyvale, California, with an ultimate completion date of August 11, 2025. The contract carries no set-aside designation and represents a continuation of...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F7SM9Delivery Order
This delivery order, valued at $13.6K, was awarded on July 21, 2025, to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, by the Medical Supply Chain within the Department of Defense. The contract, which carries no set-aside designation and employs firm fixed-price terms, is scheduled for completion by July 28, 2025. Based on the contract nomenclature (XPCOV2/FLU/RSV-10), this delivery order pertains to diagnostic testing for COVID-19, influenza, and respiratory syncytial virus (RSV), consistent with Cepheid's core product offerings of GeneXpert diagnostic systems and molecular reagents. This delivery order likely derives from one of Cepheid's two existing Indefinite Delivery Vehicle (IDV) contracts with the Veterans Administration, most notably the $32.8M single-award IDV with VA's Veterans Integrated Service Network 6, which provides molecular diagnostic testing system reagents and assays through September 30, 2030. Cepheid's established federal presence across multiple VA networks and the Defense Health Agency, combined with its specialized expertise in infectious disease diagnostics, positions the company as a critical supplier of diagnostic capabilities to federal healthcare systems. The compressed performance timeline and modest ceiling value suggest this delivery order addresses immediate operational diagnostic needs within the defense healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 7/21/25 |